EGS21

Thuốc Gốc

Small Molecule

EGS21(TM) is a beta-D-glucosylceramide (GC) compound. It is a potential therapeutic for treating immune mediated disorders. GC is a glycolipid that has been shown by Enzo scientists and collaborators to act as an anti-inflammatory agent in animal model systems, and therefore is being evaluated as an important candidate drug in the treatment of various immune mediated diseases, such as Crohn's disease, hepatitis, non-alcoholic steatohepatitis (NASH) or fatty liver and HIV.

Chỉ Định : Investigated for use/treatment in crohn's disease, hepatitis (unspecified), and liver disease.

Tài Liệu Tham Khảo Thêm

drugbank

http://www.drugbank.ca/drugs/DB05056

Bạn thấy hài lòng ?

Bạn chưa hài lòng ?

... loading